Nextech Invest

Nextech Invest accounts for 23 tracked companies with verified cap-table data, 23 of which disclose round sizes totalling $4.9B. The median disclosed raise is $136M, and the largest is Autolus at $1.2B, ahead of Vividion Therapeutics ($362M) and FogPharma ($323M).

The names that recur most often on these portfolio cap tables are Nextech Invest (24 companies), RA Capital Management (8 companies), Casdin Capital (7 companies), Third Rock Ventures (5 companies), Boxer Capital (5 companies), OrbiMed (5 companies). By latest disclosed round, the market skews Series C (9), Series A (7), Series B (4), IPO (1).

• Companies tracked: 23
• Disclosed funding total: $4.9B across 23 companies
• Median disclosed raise: $136M
• Largest raise: Autolus — $1.2B
• Stage mix: Series C 9 · Series A 7 · Series B 4 · IPO 1
• Most recent dated round: 2026-06-30

Best funded Nextech Invest companies

1. Autolus — $1.2B (latest: IPO)
2. Vividion Therapeutics — $362M (latest: Series B)
3. FogPharma — $323M (latest: Series D)
4. Flare Therapeutics — $287M (latest: Series C)
5. Boundless Bio — $256M (latest: Series C)
6. ProfoundBio — $250M (latest: Series B)
7. Escient Pharmaceuticals — $238M (latest: Series C)
8. Alterome Therapeutics — $231M (latest: Series A)
9. Kinnate Biopharma — $195M (latest: Series C)
10. Black Diamond Therapeutics — $194M (latest: Series C)
11. Tyra Biosciences — $156M (latest: Series B)
12. A2 Biotherapeutics — $136M (latest: Series C)
13. Idrx — $122M (latest: Series A)
14. Blueprint Medicines — $115M (latest: Series C)
15. Jounce Therapeutics — $103M (latest: Series B)

Nextech Invest — related firms and companies (56)

• Autolus
• Vividion Therapeutics
• FogPharma
• Flare Therapeutics
• Boundless Bio
• ProfoundBio
• Escient Pharmaceuticals
• Alterome Therapeutics
• Investors like CAVU Consumer Partners
• Investors like ACME Capital
• Investors like Meritech Capital Partners
• Investors like Draper Associates
• Investors like Blockchain Capital
• Investors like Lightbank
• Investors like DCM Ventures
• Firms like GV
• Investors like Correlation Ventures
• Tyra Biosciences
• Blueprint Medicines
• Synnovation Therapeutics
• PMV Pharmaceuticals
• Delphia Therapeutics
• Investors like Benchmark
• Investors like Menlo Ventures
• Investors like Casdin Capital
• Investors like Maven Ventures
• Investors like Fika Ventures
• Investors like Maveron
• Investors like Liquid 2 Ventures
• Investors like Plug and Play
• Investors like Trinity Ventures
• Investors like Peak XV Partners
• Investors like RRE Ventures
• Investors like Greycroft
• Black Diamond Therapeutics
• Idrx
• AmbAgon Therapeutics
• Context Therapeutics
• IconOVir Bio
• Investors like Nextech Invest
• Investors like Foundation Capital
• Investors like BoxGroup
• Investors like Ventioneers
• Investors like Acre Venture Partners
• Investors like Service Provider Capital
• Investors like Wellington Management
• Investors like Alumni Ventures
• Investors like GIC
• Investors like boldstart ventures
• Investors like Western Technology Investment
• Investors like Sapphire Ventures
• Kinnate Biopharma
• A2 Biotherapeutics
• Jounce Therapeutics
• Stipple Bio
• Mersana Therapeutics

Nextech Invest profile · All research reports